Information on support groups, facts, medication and causes of schizophrenia.

Information for professionals working with people with psychosis.

A schizophrenia resource tool for the media, clinicians and health professionals. It features audiopresentations of symposia from major international psychiatry conferences as well as abstracts, press releases and fact sheets. Sponsored by the makers of Seroquel, AstraZeneca.

A portal for knowledge and understanding of schizophrenia.

Information about schizophrenia, its causes, and methods of treatment.

Schizophrenia resource includes news and information on mental health issues.

National organization that raises and distributes funds to find the causes, cures, better treatments, and prevention of severe brain disorders. Provides instructions and contact information for submitting grant proposals.

A grass roots, self-help, support and advocacy organization. Medical and legislative news, book reviews, meeting announcements and links to other sites can be found here.

Located Santa Barbara, CA, Phoenix House is a residential program for individuals diagnosed with schizophrenia. Site contains information on schizophrenia and related mental illnesses.

International schizoprhenia resource site, intended for clinicians and health care professionals.

Historical review on psychosis since the nineteenth century, descriptive catalogue of psychotic symptoms, and the theory of Mental Automatism.

Information on schizophrenia. Articles, counseling services, and a free mailing list.

Information on schizophrenia and therapy approaches for patients, family members, and caregivers - newsletters, articles, recommended reading, and resources.

Provides patients, family members, and caregivers with information on a variety of important mental health topics including schizophrenia and other common mental illnesses.

Alternative views on schizophrenia and psychiatry.

Providing education and information on this disease.

Clozapine is indicated for the treatment of severe schizophrenia in patients who fail standard therapy. This program is the national generic clozapine registry for monitoring patients who are receiving ZGP clozapine.

Offers details on schizophrenia, its symptoms and treatment through atypical antipsychotic medication.